“…For affected individuals and their relatives, AN appears as a malign developmental influence (Lindstedt, Kjellin, & Gustafsson, 2017). However, the rates of dropout from treatment lie between 20% and 50% (Dejong, Broadbent, & Schmidt, 2012;Huas et al, 2011;Lindstedt et al, 2017) and the rates of relapses within 1 year after treatment range between 20% and 40% (Carter et al, 2012;Herpertz-Dahlmann et al, 2014). In recent years, the outcome of AN treatments (e.g., remission rates and weight recovery) has improved, particularly for adolescent patients (Lindstedt et al, 2017;Zipfel, Giel, Bulik, Hay, & Schmidt, 2015).…”